Products

QFR
QFR Solutions bv
Cardiology AI
QFR by QFR Solutions bv is an FDA-cleared AI-powered medical software for the visualization and quantitative flow ratio (QFR) analysis of X-ray angiographic images of coronary vessel segments, aiding cardiologists in lesion assessment.

See all 1 product →

About QFR Solutions bv

QFR Solutions bv is the foundational entity behind the Quantitative Flow Ratio (QFR) technology, an innovative, non-invasive software solution designed for the comprehensive assessment of coronary physiology directly from angiographic images. Leveraging advanced artificial intelligence and deep learning algorithms, this tool empowers cardiologists and radiologists to accurately evaluate the functional severity of lesions within coronary arteries. It offers a significant advancement over traditional invasive methods like Fractional Flow Reserve (FFR) by eliminating the need for pressure wires and pharmacologically induced hyperemia, thereby streamlining procedures and potentially reducing patient discomfort and procedural risks.

The Medis QFR® solution, a registered trademark of QFR Solutions bv, provides critical insights for clinical decision-making concerning the diagnosis and optimal treatment strategies for coronary artery disease. Physicians can utilize the software for detailed 3D vessel reconstruction, precise measurement of lesion length, accurate determination of stenosis percentage, and quantification of pressure drop across coronary vessels. This technology is intended to support the evaluation of interventions and drug therapies, ultimately contributing to improved patient outcomes in cardiovascular care.

Focus Areas

Coronary physiology assessment angiography-derived FFR AI in cardiology diagnosis and treatment of coronary artery disease (CAD) percutaneous coronary intervention (PCI) planning and evaluation microvascular dysfunction assessment

Business Intelligence

Key InvestorsVan Herk Groep, MeVis Medical Solutions, Leiden University, Van Herk Ventures
PartnershipsTerumo Health Outcomes, GE HealthCare
AcquisitionsAdvanced Medical Imaging Development (AMID)
TechnologyAI and Deep Learning, computational fluid dynamics (CFD) principles, 3D Quantitative Coronary Angiography (QCA), X-ray image-based solution, browser-based software
FDA Clearances1 cleared products (estimated)

What Physicians Need to Know

Coronary Physiology Assessment & Angiography-Derived FFR
Medis QFRu00ae is a novel, non-invasive software solution that accurately and rapidly computes Fractional Flow Reserve (FFR) directly from standard coronary angiograms. It eliminates the need for invasive pressure wires and hyperemic agents like adenosine, significantly reducing patient risk, discomfort, and procedural time and cost. The technology requires only two angiographic projections for optimal 3D vessel reconstruction and has demonstrated excellent correlation and agreement with invasive FFR and iFR measurements.
AI in Cardiology
Powered by artificial intelligence (AI) and deep learning, Medis QFRu00ae utilizes advanced algorithms for precise 3D vascular model reconstruction and blood flow boundary conditions. AI-enabled end-diastolic frame selection streamlines the analysis process, saving valuable time and minimizing user variability. Deep learning further ensures precise alignment between angiographic projections, leading to consistent and reliable measurements.
Diagnosis and Treatment of Coronary Artery Disease (CAD)
The solution assesses the functional severity of epicardial artery disease, aiding in the identification of functionally significant lesions and CAD patterns for treatment planning. QFR-guided percutaneous coronary intervention (PCI) has been shown to significantly reduce the risk of coronary PCI by 35% and improve patient outcomes. Medis QFRu00ae holds Class IB, IA, and IC recommendations in the 2024 ESC Guidelines for epicardial artery stenosis, multivessel disease, and chronic heart failure management, respectively.
PCI Planning and Evaluation
Medis QFRu00ae is a comprehensive tool for both pre-procedural planning and post-procedural optimization of PCI. QFR-based virtual PCI has proven superior to conventional angiography-based PCI in achieving optimal post-PCI physiological results and can influence the procedural plan in over a quarter of patients. It assists physicians in determining appropriate stent size and length for optimal positioning and placement, and in predicting post-PCI QFR values.
Microvascular Dysfunction Assessment
QFR technology extends its utility to microcirculatory assessment, enhancing its value as a comprehensive physiology platform. The newest QFR technology, including QFR-IMR, offers rapid coronary vessel analysis for assessing microvascular dysfunction. Non-hyperemic IMR angio measurements provide a quicker and less invasive alternative, reducing reliance on vasodilator agents. QFR computation has also been suggested as a useful tool to predict microvascular dysfunction (MVD) after ST-segment-elevation myocardial infarction (STEMI).
Physician Tip

For optimal utilization of Medis QFRu00ae:n1. **Ensure Optimal Angiographic Projections:** Acquire at least two angiographic projections, ideally more than 25 degrees apart, for accurate 3D reconstruction and QFR computation.n2. **Integrate into Workflow:** Leverage QFR for both pre-PCI planning (lesion identification, stent sizing) and post-PCI evaluation (confirming physiological improvement) to enhance decision-making and patient outcomes.n3. **Assess Microvascular Dysfunction:** Consider using QFR-IMR for a rapid, non-invasive assessment of microvascular dysfunction, particularly in STEMI patients or for stratifying non-culprit lesions.n4. **Embrace Automation:** Utilize the AI-powered automation features for efficient workflow and to minimize user variability in analysis, ensuring consistent and reliable measurements.n5. **Prioritize Patient Safety and Efficiency:** Capitalize on the wire-free and adenosine-free nature of QFR to reduce procedural risks, patient discomfort, and overall cath lab costs and time.

Medis QFRu00ae is delivered in strategic collaboration with ACIST Medical Systems, Inc. and features exclusive integration with GE HealthCare IGS imaging systems to optimize workflow speed. The technology is also highlighted in symposiums in collaboration with GE Healthcare and Biotronik. This demonstrates a strong commitment to seamless integration within existing cath lab infrastructures, facilitating broader adoption and efficient use.

Products by QFR Solutions bv

1 product in the directory

QFR
QFR Solutions bv
Cardiology AI
QFR by QFR Solutions bv is an FDA-cleared AI-powered medical software for the visualization and quantitative flow ratio (QFR) analysis of X-ray angiographic images of coronary vessel segments, aiding cardiologists in lesion assessment.

What the Web Says

It appears there might be a misunderstanding in the search results as 'QFR Solutions bv' did not yield direct reviews. Instead, the search results provided reviews for several different companies with 'Q' in their name or related to 'Q' products, such as 'Paid' (a product reviewed on G2), 'Q2 Platform', 'QReserve', 'Q Research Software', and 'QA Sphere'. Therefore, a direct summary for 'QFR Solutions bv' cannot be provided from the given information. The reviews available are for various software solutions, primarily focusing on ease of use, automation, and scheduling capabilities.

Overall: Mixed

Strengths

  • Ease of use and user-friendly interface for various software products
  • Automation capabilities for billing, invoicing, and payment tracking
  • Efficient task management and streamlined operations
  • Flexible and user-friendly scheduling platforms
  • Comprehensive test case management and AI-powered features for QA software
  • Good customer support for some products

Limitations

  • Challenging initial setup for some complex configurations
  • Learning curve for first-time users of certain software
  • User interface could be more modern or attractive for some products
  • Minor delay in data syncing for one product
  • Clunky interface and difficulty visualizing bookings on dashboards for a scheduling platform
  • Low pay for high-yield work and poor work-life balance reported by employees of one company (Q2 Solutions)

Based on reviews from: G2, Capterra, Indeed.com

Last updated: 2026-07-20

Videos

News, demos, and interviews about QFR Solutions bv.

Loading videos...

Videos load interactively. If none appear, search YouTube for QFR Solutions bv →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

QFR Solutions bv is associated with Medis QFRu00ae, a proprietary software solution that provides image-based functional assessment of coronary obstructions from standard coronary angiograms. It leverages advanced computational fluid dynamic principles and artificial intelligence to accurately assess the physiologic significance of a coronary arterial segment without the need for pressure wires or hyperemic agents.
Medis QFRu00ae offers a non-invasive, wire-free, and adenosine-free alternative to traditional FFR, reducing procedural time, costs, and patient discomfort. Clinical studies have shown excellent correlation and diagnostic performance between QFR and pressure-derived FFR for identifying functionally significant lesions.
Artificial intelligence and deep learning power Medis QFRu00ae to streamline workflows, enabling automatic vessel selection, pathline, and contour detection for precise 3D vessel reconstruction. This AI-driven approach enhances the accuracy of assessing coronary lesion severity and morphology, guiding informed decisions for CAD diagnosis and revascularization planning.
Medis QFRu00ae is utilized for pre-PCI planning, including virtual PCI, which has demonstrated superiority over conventional angiography-based PCI in achieving optimal post-PCI physiological results. It also aids during PCI to confirm lesion severity and post-PCI to evaluate physiological improvement and long-term safety and effectiveness.
Yes, Medis QFRu00ae has capabilities for microcirculatory assessment, including the angiography-derived Index of Microvascular Resistance (QFR-IMR). This non-wire-based technique offers a quicker and less invasive alternative for assessing microvascular dysfunction, particularly in conditions like STEMI.
Medis QFRu00ae 3.0 has received FDA clearance in the United States and market clearance in the EU, Canada, Australia, and other regions. The company offers a 'Pay per Use' model where healthcare providers purchase analysis tokens, allowing for cost-effective integration into existing cath lab workflows.
QFR Solutions bv is closely associated with Medis Medical Imaging bv, which provides support and has strategic partnerships with companies like ACIST Medical Systems and GE HealthCare for integrated solutions. Medis Medical Imaging has over 30 years of experience in cardiovascular imaging, indicating a stable and established presence in the medical technology field.

Related Companies

Intelligent Voice AI (IVAI) is an agentic AI platform that deploys AI voice agents specifically designed for healthcare, insurance, legal, and home services businesses. For physicians and medical practices, IVAI’s Evolve AI Agents act as an AI workforce, not just an answering service, handling a comprehensive range of administrative and operational tasks. These agents can […]

Dext, formerly known as Receipt Bank, is a company that specializes in bookkeeping automation, leveraging data, technology, and applied AI to enhance productivity and efficiency for businesses, accountants, and bookkeepers. [3, 16] Their platform is designed to streamline financial document management and automate bookkeeping tasks, aiming to simplify the accounting process and enable more informed […]

Cortex (https://www.cortex.app) is an AI-powered internal developer portal designed to enhance engineering excellence and streamline software development workflows. For physicians, this translates to a platform that can indirectly improve healthcare technology by enabling engineering teams to build more reliable, secure, and efficient software. The platform helps in cataloging, scoring, and assigning actions to improve service […]

Nino is an AI-powered financial planning and tax service that aims to provide comprehensive financial guidance. For physicians, Nino’s AI software can help manage income, student loans, and plan career transitions, such as moving from training to practice or considering practice ownership. The platform allows physicians to view loans, income, and savings in one place, […]

Coral AI is a healthcare artificial intelligence company that aims to streamline administrative workflows for healthcare providers, ultimately accelerating patient access to care. The company’s AI-driven platform integrates with existing healthcare systems, including EHRs, fax lines, and payer portals, to automate complex administrative tasks. This includes patient intake, prior authorizations, billing, compliance, and patient outreach. […]

SamaCare is a healthcare AI company that provides a cloud-based workflow intelligence platform designed to streamline the prior authorization process for specialty medications. The company’s platform aims to reduce the administrative burden on medical practices, improve approval rates, and add predictability to patient care. By digitizing the often manual and paper-heavy prior authorization process, SamaCare […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.